Position in LLY
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$2,048,626
+$436,270 QoQ
Shares Held
1,708
-2.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#2,481
of 4,605 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cornell Pochily Investment Advisors, Inc. holds $19,372,779 across 8 Drug Manufacturers - General names. LLY ranks #4 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
24,344 | $6,125,924 | |
| 2 | JNJ |
Johnson & Johnson
|
18,975 | $4,819,080 | |
| 3 | AMGN |
Amgen Inc
|
7,009 | $2,538,099 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
1,708 | $2,048,626 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
10,724 | $1,354,870 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,019 | $1,030,441 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,451 | $775,046 | |
| 8 | PFE |
Pfizer Inc
|
28,268 | $680,693 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,048,626 | 1,708 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,612,356 | 1,753 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,721,637 | 1,602 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,222,326 | 1,602 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $1,233,995 | 1,583 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $1,295,852 | 1,569 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,203,548 | 1,559 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,380,294 | 1,558 | Shares | Sole | 2024-10-15 | |
| 2024-03-31 | $1,032,352 | 1,327 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $772,951 | 1,326 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $712,771 | 1,327 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $705,345 | 1,504 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $516,503 | 1,504 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $538,882 | 1,473 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $443,959 | 1,373 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $437,062 | 1,348 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $386,026 | 1,348 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $366,820 | 1,328 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $306,834 | 1,328 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $304,802 | 1,328 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $248,096 | 1,328 | Shares | Sole | 2021-04-22 | |
| 2020-06-30 | $262,688 | 1,600 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $221,952 | 1,600 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||